-Conference Call
B. Riley Securities Maintains Buy on Bath & Body Works, Lowers Price Target to $44
B. Riley Securities analyst Susan Anderson maintains Bath & Body Works (NYSE:BBWI) with a Buy and lowers the price target from $67 to $44.
Related Posts
Good News For Sleep Disorder Patients – Takeda’s Therapy Shows Promise In Mid-Stage Study
Takeda's Phase 2b trial results for TAK-861, an oral orexin receptor 2 agonist, in narcolepsy type 1 patients. Global Phase 3 trials planned for fiscal year 2024.
Bloomberg Reported Earlier, Dell To Eliminate ~ 6,650 Jobs, ~5% Of Workforce
https://www.bloomberg.com/news/articles/2023-02-06/dell-dell-lays-off-about-6-650-employees-in-latest-tech-cuts?srnd=premium